2018 Symposium

2017 Symposium

2017 Symposium Photos

2016 Symposium

2015 Symposium

2015 Agenda and Bios

2015 Symposium Photos

2014 Symposium

2014 Agenda and Bios

2013 Featured Talks

2013 Symposium Photos

Previous Symposia

2017 Symposium Featured Talks


Please enjoy the featured talks below from our recent symposium. Thank you!

Please note: These videos are for private viewing only. Any unintended use of the videos without consent is prohibited.

Keynote Presentation: Duane Roth Award Lecture
Partnering for Patients in the Academy and Industry


Sandra Horning, MD
Genentech


Keynote Presentation:
Finding Therapeutic Targets for Aggressive Prostate Cancer


Owen Witte, MD
UCLA Broad Stem Cell Research Center


Epigenetics of GBM Cancer Stem Cells


Laure Escoubet, PhD
Celgene




Understanding and Targeting Spliceosomal Gene Mutations in Cancer


Silvia Buonamici, PhD
H3 Biomedicine




Introduction


Tom Marsilje, PhD
Patient Advocate




Patient Advocacy Panel Discussion: What Does Real Time Translation Mean for Patients?


Moderator:
Andrew Pollack


Panel Members:
Ezra Cohen, MD, UC San Diego Moores Cancer Center
Tom Marsilje, PhD, Patient Advocate
Stephen Schoenberger, PhD, La Jolla Institute for Allergy and Immunology, Human Longevity Inc.


Targeting Hyaluronan in Pancreas Cancer


Helen Torley, MB ChB, MRCP
Halozyme




RON kinase as a Modulator of the Pancreatic Cancer Microenvironment


Andrew Lowy, MD
UC San Diego Moores Cancer Center




Organizer Welcome


Ida Deichaite, PhD
UC San Diego Moores Cancer Center





2017 Symposium


The 13th Moores Cancer Center Industry/Academia Translational Oncology Symposium was held on Thursday, February 16, 2017. We thank all attendees for a successful symposium, and look forward to the collaborations being made.

Keynote Speaker
Duane Roth Award Lecture

Partnering for Patients in the Academy and Industry

Sandra Horning, MD

Head of Global Product Development
Chief Medical Officer
Genentech
[+] Biography

Keynote Speaker

Finding Therapeutic Targets for Aggressive Prostate Cancer

Owen N. Witte, MD

Director, UCLA Broad Stem Cell Research Center
Distinguished Professor of Microbiology, Immunology and Molecular Genetics
University of California, Los Angeles
Investigator, Howard Hughes Medical Institute
[+] Biography

Baseline tumoral IFNγ mRNA and PD-L1 protein expression associated with response and overall survival in durvalumab-treated NSCLC patients
Carlos Bais, PhD

Director R&D, Translational Medicine Oncology
Medimmune
[+] Biography

Understanding and Targeting Spliceosomal Gene Mutations in Cancer
Silvia Buonamici, PhD

Director
H3 Biomedicine Inc.
[+] Biography

Inhibition of microglial PI3Kg suppresses glioblastoma tumoigenicity by disrupting IL11-STAT3-MYC signaling.
Clark Chen, MD, PhD

Chief of Stereortactic and Radiosurgery
UC San Diego Moores Cancer Center
[+] Biography

Targeting KRAS addicted lung cancer
David Cheresh, PhD

Distinguished Professor of Pathology
Associate Director, Innovation and Industry Alliances
UC San Diego Moores Cancer Center
[+] Biography

Epigenetics of GBM Cancer Stem Cells
Laure Escoubet, PhD

Director, Head of Epigenetic Drug Discovery
Celgene
[+] Biography

Combining VEGF inhibitors with strategies to manipulate the immune system in cancer
Napoleone Ferrara, MD

Senior Deputy Director for Basic Science
Distinguished Professor of Pathology
UC San Diego Moores Cancer Center
[+] Biography

Rationale development of patient driven combinations with ibrutinib
Danelle James, MD, MAS

Head of Oncology
Pharmacyclics
[+] Biography

RNA Processing Deregulation as Driver of Cancer Stem Cell Generation
Catriona Jamieson, MD, PhD

Associate Professor of Medicine
Chief, Division of Regenerative Medicine
Director, CIRM Alpha Stem Cell Clinic at UC San Diego
Deputy Director, Sanford Stem Cell Clinical Center
UC San Diego Moores Cancer Center
[+] Biography

RON kinase as a Modulator of the Pancreatic Cancer Microenvironment
Andrew Lowy, MD, FACS

Chief, Division of Surgical Oncology
Professor of Surgery
UC San Diego Moores Cancer Center
[+] Biography

Next Generation Antisense Inhibitors: Targeting difficult to drug pathways in Cancer
Robert MacLeod, PhD

Vice President Oncology Discovery
Ionis Pharmaceuticals
[+] Biography

A Preclinical Evaluation of Niraparib Efficacy as Monotherapy, Following Platinum and Relative to Olaparib in Patient-Derived Ovarian Xenograft Tumor Models
Keith Mikule, PhD

Senior Director Discovery Pharmacology, Strategic Partnerships
TESARO
[+] Biography

Novel cancer therapeutics from the immunomicrobiome
Jackie Papkoff, PhD

Senior Vice President & Head of Research
Evelo Biosciences
[+] Biography

MM-141, a bispecific antibody against IGF-IR and ErbB3 designed to overcome an intrinsic resistance mechanism of IGF-IR Inhibitors
Birgit Schoeberl, PhD

Head of Discovery, SVP
Merrimack Pharmaceuticals
[+] Biography

Translational control of normal and malignant stem cells
Rob Signer, PhD

Assistant Professor of Medicine
UC San Diego Moores Cancer Center
[+] Biography

Targeting Hyaluronan in Pancreas Cancer
Helen Torley, MB ChB, MRCP

President and Chief Executive Officer
Halozyme, Inc.
[+] Biography

Multivalent antibody engineering to get DR5 agonists back on TRAIL
Klaus Wagner, MD, PhD

Chief Medical Officer
Inhibrx
[+] Biography

Junior Scientist Presentation: Pro-inflammatory pathways point the way to novel therapeutic targets for multiple myeloma

Leslie Crews, PhD

UC San Diego Moores Cancer Center
Sanford Consortium for Regenerative Medicine
[+] Biography


Patient Advocacy Panel Discussion:
What does Real Time Translation Mean for Patients?

Moderator: Andrew Pollack

The New York Times
[+] Biography

Panel Members:

Ezra Cohen, MD

Professor of Medicine
Associate Director, Translational Science
UC San Diego Moores Cancer Center
[+] Biography

Tom Marsilje, PhD

Patient Advocate
[+] Biography

Tony Reid, MD, PhD

Professor of Clinical Medicine
UC San Diego Moores Cancer Center
[+] Biography

Stephen Schoenberger, PhD

Professor, Division of Cellular Immnology
La Jolla Institute for Allergy and Immunology,
Head of Cancer Vaccines, Human Longevity Inc.
[+] Biography

We Thank Our Sponsors: